Table 3.
Prevalence of Any HPV or Quadrivalent Vaccine-Type HPV in Anal and/or Oral Specimens, by Characteristics of Participating Transgender Women and Gay, Bisexual, and Other Men Who Have Sex With Men
| Characteristic | Total | Any HPV Type | ≥1 4vHPV Type | ||
|---|---|---|---|---|---|
| N | n (%) | P | n (%) | P | |
| Total | 1767 | 1253 (100) | - | 475 (100) | - |
| City | |||||
| Chicago | 617 | 405 (65.6) | <.001 | 149 (24.2) | .13 |
| Los Angeles | 446 | 318 (71.3) | 121 (27.1) | ||
| Seattle | 704 | 530 (75.3) | 205 (29.1) | ||
| Age, years | |||||
| 18–21 | 628 | 393 (62.6) | <.001 | 112 (17.8) | <.001 |
| 22–26 | 1139 | 860 (75.5) | 363 (31.9) | ||
| Gender Identity | |||||
| Male | 1671 | 1182 (70.7) | .075 | 449 (26.9) | .98 |
| Female/transgender female | 53 | 44 (83.0) | 14 (26.4) | ||
| Other/unknown | 43 | 27 (62.8) | 12 (27.9) | ||
| Race/ethnicity | |||||
| Non-Hispanic white | 545 | 364 (66.8) | .087 | 146 (26.8) | .69 |
| Non-Hispanic black | 261 | 188 (72.0) | 78 (29.9) | ||
| Asian/Pacific Islander | 136 | 105 (77.2) | 35 (25.7) | ||
| Hispanic | 557 | 400 (71.8) | 151 (27.1) | ||
| Other/unknown | 268 | 196 (73.1) | 65 (24.3) | ||
| Sexual orientation | |||||
| Gay/homosexual | 1295 | 942 (72.7) | .014 | 365 (28.2) | .54 |
| Straight/heterosexual | 29 | 21 (72.4) | 6 (20.7) | ||
| Other/unknown | 443 | 290 (65.5) | 113 (25.5) | ||
| Lifetime number of sex partners of any sex | |||||
| ≤5 | 247 | 117 (47.4) | <.001 | 30 (12.1) | <.001 |
| 6–10 | 276 | 178 (64.5) | 55 (19.9) | ||
| 11–20 | 388 | 256 (66.0) | 83 (21.4) | ||
| >20 | 801 | 659 (82.3) | 282 (35.2) | ||
| Other/unknown | 55 | 43 (78.2) | 25 (45.4) | ||
| Most recent HIV test result | |||||
| Positive | 139 | 127 (91.4) | <.001 | 70 (50.4) | <.001 |
| Negative or unknown | 1628 | 1126 (69.2) | 405 (24.9) | ||
| Ever received any HPV vaccine | |||||
| No, none | 687 | 474 (69.0) | .35 | 217 (31.6) | .001 |
| Yes, any | 704 | 510 (72.4) | 161 (22.9) | ||
| Other/unknown* | 376 | 269 (71.5) | 97 (25.8) |
Abbreviations: HIV, human immunodeficiency virus; HPV, human papillomavirus; 4vHPV, quadrivalent HPV vaccine.
NOTE: Bold font indicates significance of χ 2 analysis at P < .05.
*Includes participants who were unsure of their HPV vaccination history or did not respond.